Treatment and Maintenance Therapy in Advanced Ovarian Cancer

Nebraska Oncology Society
Avatar

Targeting DNA Damage Response in Ovarian Cancer: Are PARPi Just the Beginning?

By Nebraska Oncology Society FEATURING Kathleen Moore
By Nebraska Oncology Society FEATURING Kathleen Moore
736 views
October 25, 2021
Comments 0
Login to view comments. Click here to Login
13:44

Niraparib Therapy in Patients With Newly Diagnosed Advanced Ovarian …

Antonio González-Martín

227 views
16:30

2021 Updates on Gynecologic Oncology: Impact on Patients, Overview o…

University of Colorado Cancer Center

B. Bitler, S. Guntupalli, C. Walsh

335 views
11:38

Labeled Indications for PARPi Monotherapy & PARPi+ Bevacizumab: How …

Michael Birrer

347 views
22:23

PARPi in 1L Advanced Ovarian Cancer: PFS Data for Olaparib, Nirapari…

Angela George

378 views
24:01

Updates in Ovarian Cancer Management: Treatment Options and Molecula…

Total Health

M. Yatsko

213 views
17:50

Updates From the PRIMA Trial: Niraparib as 1L Maintenance in Advance…

Kenrick Ng

839 views
23:10

Targeted Therapy for Advanced Ovarian Cancer

Ramez Eskander

503 views
20:53

Advances in IO Maintenance Treatment of Ovarian Cancer

CECOG Academy

C. Grimm

380 views
23:01

PARPi in DNA Repair-Associated Cancers: Predictors of Benefit, Mecha…

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

G. Fleming

289 views
11:37

Developments in Frontline Therapy in Ovarian Cancer

Jonathan Ledermann

382 views
05:33

PARPi Maintenance Therapy in Advanced Ovarian Cancer: A Brief Review

Catherine Watson

256 views
11:28

SGO 2022: Recognition and Management of Side Effects Associated With…

SGO 2022 Conference Coverage on VuMedi

M. Raza Mirza

133 views
06:03

SGO 2022 on a Phase 2 OVARIO Study of Niraparib + Bevacizumab in Adv…

SGO 2022 Conference Coverage on VuMedi

M. Hardesty

289 views